Literature DB >> 14665695

Arf tumor suppressor promoter monitors latent oncogenic signals in vivo.

Frederique Zindy1, Richard T Williams, Troy A Baudino, Jerold E Rehg, Stephen X Skapek, John L Cleveland, Martine F Roussel, Charles J Sherr.   

Abstract

Induction of the Arf tumor suppressor gene by elevated thresholds of mitogenic signals activates a p53-dependent transcriptional response that triggers either growth arrest or apoptosis, thereby countering abnormal cell proliferation. Conversely, Arf inactivation is associated with tumor development. Expression of Arf in tissues of adult mice is difficult to detect, possibly because its induction leads to the arrest or elimination of incipient tumor cells. We replaced coding sequences of exon 1beta of the mouse cellular Arf gene with a cDNA encoding GFP, thereby producing Arf-null animals in which GFP expression is driven by the intact Arf promoter. The Arf promoter was induced in several biologic settings previously shown to elicit mouse p19Arf expression. Inactivation of Arf in this manner led to the outgrowth of tumor cells expressing GFP, thereby providing direct evidence that the Arf promoter monitors latent oncogenic signals in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14665695      PMCID: PMC307670          DOI: 10.1073/pnas.2536808100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases.

Authors:  M Yang; E Baranov; P Jiang; F X Sun; X M Li; L Li; S Hasegawa; M Bouvet; M Al-Tuwaijri; T Chishima; H Shimada; A R Moossa; S Penman; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  p16INK4A and p19ARF act in overlapping pathways in cellular immortalization.

Authors:  A Carnero; J D Hudson; C M Price; D H Beach
Journal:  Nat Cell Biol       Date:  2000-03       Impact factor: 28.824

3.  p53-independent functions of the p19(ARF) tumor suppressor.

Authors:  J D Weber; J R Jeffers; J E Rehg; D H Randle; G Lozano; M F Roussel; C J Sherr; G P Zambetti
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

4.  Dual inactivation of RB and p53 pathways in RAS-induced melanomas.

Authors:  N Bardeesy; B C Bastian; A Hezel; D Pinkel; R A DePinho; L Chin
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

5.  A gene hypermethylation profile of human cancer.

Authors:  M Esteller; P G Corn; S B Baylin; J G Herman
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

6.  Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

Authors:  C M Eischen; J D Weber; M F Roussel; C J Sherr; J L Cleveland
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

7.  Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.

Authors:  J J Jacobs; B Scheijen; J W Voncken; K Kieboom; A Berns; M van Lohuizen
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

8.  Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.

Authors:  K Inoue; R Wen; J E Rehg; M Adachi; J L Cleveland; M F Roussel; C J Sherr
Journal:  Genes Dev       Date:  2000-07-15       Impact factor: 11.361

9.  Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d).

Authors:  F Zindy; W den Besten; B Chen; J E Rehg; E Latres; M Barbacid; J W Pollard; C J Sherr; P E Cohen; M F Roussel
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

Review 10.  The genetics of malignant melanoma: lessons from mouse and man.

Authors:  Lynda Chin
Journal:  Nat Rev Cancer       Date:  2003-08       Impact factor: 60.716

View more
  70 in total

Review 1.  The essence of senescence.

Authors:  Thomas Kuilman; Chrysiis Michaloglou; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

2.  Protein kinase CK2 is a central regulator of topoisomerase I hyperphosphorylation and camptothecin sensitivity in cancer cell lines.

Authors:  Keya Bandyopadhyay; Ruth A Gjerset
Journal:  Biochemistry       Date:  2011-01-12       Impact factor: 3.162

3.  ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF.

Authors:  Abhishek Datta; Jayita Sen; Jussara Hagen; Chandrashekhar K Korgaonkar; Michael Caffrey; Dawn E Quelle; Douglas E Hughes; Timothy J Ackerson; Robert H Costa; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

4.  Expression of Dmp1 in specific differentiated, nonproliferating cells and its regulation by E2Fs.

Authors:  A Mallakin; P Taneja; L A Matise; M C Willingham; K Inoue
Journal:  Oncogene       Date:  2006-07-31       Impact factor: 9.867

5.  Differing tumor-suppressor functions of Arf and p53 in murine basal cell carcinoma initiation and progression.

Authors:  G Y Wang; C N Wood; J A Dolorito; E Libove; E H Epstein
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

6.  Aberrant expression of p16INK4a in human cancers - a new biomarker?

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Cancer Rep Rev       Date:  2018-01-15

7.  Tissue-specific p19Arf regulation dictates the response to oncogenic K-ras.

Authors:  Nathan P Young; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

Review 8.  p53--a Jack of all trades but master of none.

Authors:  Melissa R Junttila; Gerard I Evan
Journal:  Nat Rev Cancer       Date:  2009-09-24       Impact factor: 60.716

9.  Isolation and characterization of mammalian cells expressing the Arf promoter during eye development.

Authors:  Nida S Iqbal; Lin Xu; Caitlin C Devitt; Stephen X Skapek
Journal:  Biotechniques       Date:  2014-05-01       Impact factor: 1.993

10.  p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.

Authors:  Ryan C Widau; Yanbin Zheng; Caroline Y Sung; Anna Zelivianskaia; Lauren E Roach; Karen M Bachmeyer; Tatiana Abramova; Aurelie Desgardin; Andrew Rosner; John M Cunningham; Stephen X Skapek
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.